Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) dropped 1.3% during mid-day trading on Monday . The company traded as low as $0.30 and last traded at $0.3254. 650 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 8,568 shares. The stock had previously closed at $0.3296.
Algernon Pharmaceuticals Price Performance
The stock’s 50 day moving average price is $0.31 and its 200 day moving average price is $0.19.
About Algernon Pharmaceuticals
Algernon Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel, small-molecule therapeutics. The company’s primary strategy centers on repurposing known compounds with established safety profiles to address unmet medical needs, particularly in the realms of pulmonary fibrosis, acute lung injury and central nervous system (CNS) disorders. By leveraging existing pharmacology data, Algernon aims to accelerate its development timelines while managing costs and risks typically associated with early-stage drug discovery.
The lead asset in Algernon’s pipeline is NP-120 (ifenprodil), an orally available small molecule being investigated for idiopathic pulmonary fibrosis (IPF).
Further Reading
- Five stocks we like better than Algernon Pharmaceuticals
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
